Citigroup Inc Seelos Therapeutics, Inc. Transaction History

Citigroup Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.51 - $0.93 $26,784 - $48,841	-52,518 Reduced 98.1%	1,015 $1,000
Q1 2022 May 12, 2022	BUY	$0.84 - $1.71 $23,882 - $48,617	28,431 Added 113.26%	53,533 $45,000
Q4 2021 Feb 10, 2022	BUY	$1.59 - $2.38 $21,641 - $32,394	13,611 Added 118.45%	25,102 $41,000
Q3 2021 Nov 10, 2021	BUY	$1.69 - $2.89 $19,419 - $33,208	11,491 New	11,491 $28,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $38.4M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.